LMAT — LeMaitre Vascular Inc. stock price and chart

LMAT

$83.40+1.32%

as of close, Oct 20, 2026

☾ AH $83.40 +1.32%

LeMaitre Vascular Inc.Stock · HealthcareRussell 2000 · 0.07% of IWMNasdaq Composite · 0.007% of ONEQUS Stock Market · 0.003% of VTIRussell 3000 · 0.002% of IWV

PeersMRNALLYMDTUNHJNJTMO

Share this page

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDDDDDDDDDDDDDDDDDDDEDEDEDEDEDEDEDEDEDEDEDED

20162019202120242026

20.030.040.050.060.070.080.090.0100.0110.002.0M4.0M$83.40

2026-10-20

Price$83.40

MA20$89.84

MA50$92.53

Vol1.4M

What would $1,000 invested in LMAT be worth today? →

LMAT returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $83.40
YTD price return: +2.84%
YTD total return: +3.64%
Next earnings: Nov 4, 2026 · After close
Market cap: 1.9B2016-12 470.9M2026-10 1.9B+305.0% over the window
Enterprise value: 1.9B
Shares outstanding: 22.9M2016-06 18.5M2026-06 22.9M+23.9% over the window
52W low: $78.22
52W high: $118.01
From 52W high: -29.33%
From 52W low: +6.62%
52W range: 13%

Volume

Rel volume: 0.89×
30D volume: 268.8K
30D $ vol: 21.7M

Fundamentals

Sales (ttm): 262.4M2016-06 82.2M2026-06 262.4M+219.4% over the window
Sales/share: $11.482016-06 $4.452026-06 $11.48+157.9% over the window
EPS (ttm): $2.772016-06 $0.492026-06 $2.77+464.8% over the window
FCF (ttm): 73.8M2016-09 14.1M2026-06 73.8M+424.3% over the window
FCF/share: $3.232016-09 $0.762026-06 $3.23+326.0% over the window
Book value/share: $18.382016-06 $4.492026-06 $18.38+309.6% over the window
Net margin: 25.02%2016-06 11.4%2026-06 25.0%+119.0% over the window
ROE: 15.62%2016-06 11.3%2026-06 15.6%+37.9% over the window
ROA: 10.25%2016-06 9.8%2026-06 10.3%+4.3% over the window
Current ratio: 16.312016-06 6.162026-06 16.31+164.9% over the window

Growth (CAGR, ttm) · 10Y

Sales: +11.85%2025-06-30 → 2026-06-30234.6M → 262.4M (+11.8% total)+13.99%2023-06-30 → 2026-06-30177.2M → 262.4M (+48.1% total)+11.76%2021-06-30 → 2026-06-30150.5M → 262.4M (+74.4% total)+12.32%2016-06-30 → 2026-06-3082.2M → 262.4M (+219.4% total)
Net income: +39.42%2025-06-30 → 2026-06-3047.1M → 65.7M (+39.4% total)+37.57%2023-06-30 → 2026-06-3025.2M → 65.7M (+160.4% total)+17.95%2021-06-30 → 2026-06-3028.8M → 65.7M (+128.2% total)+21.48%2016-06-30 → 2026-06-309.4M → 65.7M (+599.7% total)
FCF: +41.14%2025-06-30 → 2026-06-3052.3M → 73.8M (+41.1% total)+57.34%2023-06-30 → 2026-06-3018.9M → 73.8M (+289.6% total)+13.06%2021-06-30 → 2026-06-3040M → 73.8M (+84.7% total)+20.82%2016-03-31 → 2026-06-3010.6M → 73.8M (+594.8% total)
Shares: +1.02%2025-06-30 → 2026-06-3022.6M → 22.9M (+1.0% total)+0.90%2023-06-30 → 2026-06-3022.3M → 22.9M (+2.7% total)+1.09%2021-06-30 → 2026-06-3021.7M → 22.9M (+5.6% total)+2.16%2016-06-30 → 2026-06-3018.5M → 22.9M (+23.9% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +34.50%2025-06-30 → 2026-06-30$2.06 → $2.77 (+34.5% total)+34.78%2023-06-30 → 2026-06-30$1.13 → $2.77 (+144.9% total)+14.77%2021-06-30 → 2026-06-30$1.39 → $2.77 (+99.1% total)+18.90%2016-06-30 → 2026-06-30$0.49 → $2.77 (+464.8% total)
Sales/share: +10.72%2025-06-30 → 2026-06-30$10.37 → $11.48 (+10.7% total)+12.97%2023-06-30 → 2026-06-30$7.96 → $11.48 (+44.2% total)+10.55%2021-06-30 → 2026-06-30$6.95 → $11.48 (+65.1% total)+9.94%2016-06-30 → 2026-06-30$4.45 → $11.48 (+157.9% total)
FCF/share: +39.71%2025-06-30 → 2026-06-30$2.31 → $3.23 (+39.7% total)+55.94%2023-06-30 → 2026-06-30$0.85 → $3.23 (+279.3% total)+11.84%2021-06-30 → 2026-06-30$1.85 → $3.23 (+75.0% total)+18.27%2016-03-31 → 2026-06-30$0.58 → $3.23 (+458.4% total)
Book value/share: +14.73%2025-06-30 → 2026-06-30$16.02 → $18.38 (+14.7% total)+12.97%2023-06-30 → 2026-06-30$12.75 → $18.38 (+44.2% total)+16.46%2021-06-30 → 2026-06-30$8.58 → $18.38 (+114.2% total)+15.15%2016-06-30 → 2026-06-30$4.49 → $18.38 (+309.6% total)
Dividend/share: +25.02%2025-06-30 → 2026-06-30$0.72 → $0.90 (+25.0% total)+19.30%2023-06-30 → 2026-06-30$0.53 → $0.90 (+69.8% total)+17.03%2021-06-30 → 2026-06-30$0.41 → $0.90 (+119.5% total)+18.14%2016-06-30 → 2026-06-30$0.17 → $0.90 (+429.4% total)
Price: -5.24%2025-10-20 → 2026-10-20$88.01 → $83.40 (-5.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+19.20%2023-10-20 → 2026-10-20$49.24 → $83.40 (+69.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+8.72%2021-10-20 → 2026-10-20$54.91 → $83.40 (+51.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+15.63%2016-10-19 → 2026-10-20$19.52 → $83.40 (+327.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: -4.28%2025-10-20 → 2026-10-20$87.13 → $83.40 (-4.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+20.30%2023-10-20 → 2026-10-20$47.90 → $83.40 (+74.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+9.77%2021-10-20 → 2026-10-20$52.34 → $83.40 (+59.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+16.74%2016-10-19 → 2026-10-20$17.74 → $83.40 (+370.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 30.1×2016-12 44.752026-10 29.04-35.1% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 24.7×2016-12 30.352026-10 24.67-18.7% over the window
Fwd P/E: 25.9×
P/S (ttm)Market cap ÷ TTM revenue.: 7.3×2016-12 5.452026-10 7.27+33.3% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 4.5×2016-12 5.432026-10 4.54-16.5% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 25.8×2016-12 33.442026-10 25.84-22.7% over the window
EV/EBITDA (fy): 21.7×
EV/Sales (ttm): 7.2×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 3.87%2016-09 3.0%2026-06 3.4%+12.5% over the window
Dividend yield (fwd)Indicated annual dividend ÷ last close: the last regular payment × payments a year, from our own dividend record. Shown only for a company that pays the same amount each time (raises and cuts allowed), whose payments are on schedule and agree with the dividends it reports paying; a company whose payments vary in size, such as an unequal interim and final, has no forward figure — see the ttm yield.: 1.20%
Dividend yield (ttm)Dividends paid over the last year ÷ last close: the last full cycle of regular payments in our own dividend record. Below the forward yield after a raise, above it after a cut. Shown only when the record holds that full cycle and it agrees with the dividends the company reports paying; otherwise —.: 1.14%
Dividend/share (fwd)The indicated annual dividend: the last regular payment × payments a year, for a company that pays the same amount each time.: $1.00
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 22.9M ÷ 22.6M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -1.02%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-1.02%) + dividends paid over that year ($20.5M) ÷ market_cap_at(2025-06-30) ($1.9B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 0.07%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($1.7M) ÷ today's market cap ($1.9B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.09%2016-09 -0.5%2026-06 0.1%-115.7% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $1.7M + TTM dividends $20.5M) ÷ today's market cap ($1.9B). Same caveat as the cash buyback yield.: 1.16%2016-09 0.2%2026-06 1.0%+433.3% over the window

Vs own 10Y history

P/E: 13th
P/OI: 14th
P/S: 62nd
P/B: 40th
P/FCF: 5th

Bar = where today’s multiple sits in LMAT’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-20#

+1.32%

+2.27%

+5.74%

-17.99%

YTD

+2.84%

-5.24%

+51.88%

Financial statements

Open full LMAT financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+11.34%	+3.49%
JNJ	Johnson & Johnson	-3.94%	+2.19%
ABBV	AbbVie Inc.	+9.52%	+2.26%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+11.24%	+3.04%
MRK	Merck & Co. Inc.	+0.97%	+3.25%
NVS	Novartis AG	+9.45%	+2.29%
TMO	Thermo Fisher Scientific Inc.	+5.51%	+1.18%
AMGN	Amgen Inc.	+13.82%	+3.29%

LMAT — LeMaitre Vascular Inc. price, chart and key statistics